TMCnet News
Cidara Therapeutics to Participate in the World Antiviral Congress 2022SAN DIEGO, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology company developing long-acting therapeutics designed to improve the standard of care for patients facing serious diseases, today announced that Jeff Stein, Ph.D., President and CEO, will participate in a panel discussion at the World Antiviral Congress being held in San Diego, California from November 28-December 1, 2022. The panel will discuss pandemic preparedness and therapeutic approaches, including predictions on the next viral threat, development of broad-spectrum drugs and platforms to engineer novel therapeutics. Panel Details: Title: Therapeutic approaches to pandemic preparedness To register and view the full congress schedule, visit the World Antiviral Congress’ website here. About Cidara Therapeutics INVESTOR CONTACT: MEDIA CONTACT: |